SCHEMBL29902472

SCHEMBL29902472

COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCC1CC(NC2CCC2)C1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 13/20 0.62
▸ RET P07949 3/20 0.62
▸ PDGFRB P09619 2/20 0.62
▸ EGFR P00533 2/20 0.62
▸ FGFR1 P11362 2/20 0.62
▸ FLT1 P17948 2/20 0.62
▸ FLT4 P35916 2/20 0.62
▸ PLK4 O00444 1/20 0.62
▸ GAK O14976 1/20 0.62
▸ EPHB6 O15197 1/20 0.62
▸ RIPK2 O43353 1/20 0.62
▸ ERN1 O75460 1/20 0.62
▸ STK10 O94804 1/20 0.62
▸ MAP4K4 O95819 1/20 0.62
▸ CHEK2 O96017 1/20 0.62
▸ ABL1 P00519 1/20 0.62
▸ ERBB2 P04626 1/20 0.62
▸ LCK P06239 1/20 0.62
▸ FYN P06241 1/20 0.62
▸ CSF1R P07333 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28574930 1.00 KDR (0.62) KDRRETPDGFRBEGFRFGFR1
SCHEMBL28574929 1.00 KDR (0.62) KDRRETPDGFRBEGFRFGFR1
SCHEMBL29902455 1.00 KDR (0.62) KDRRETPDGFRBEGFRFGFR1
SCHEMBL28576675 1.00 KDR (0.62) KDRRETPDGFRBEGFRFGFR1
SCHEMBL29902448 1.00 KDR (0.62) KDRRETPDGFRBEGFRFGFR1
SCHEMBL28569253 0.98 KDR (0.62) KDRRETPDGFRBEGFRFGFR1
SCHEMBL28569254 0.98 KDR (0.62) KDRRETPDGFRBEGFRFGFR1
SCHEMBL28574178 0.98 KDR (0.62) KDRRETPDGFRBEGFRFGFR1
SCHEMBL28576578 0.98 ABCB11 (0.62) KDRRETPDGFRBEGFRFGFR1
SCHEMBL28579631 0.98 ABCB11 (0.62) KDRRETPDGFRBEGFRFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112912373-B Angiogenesis inhibitor, preparation method and application thereof 北京康辰药业股份有限公司 2022-08-23 — — CN disclosed
Send feedback